Phendimetrazine Tartrate 72989-0409-30
- Manufacturer
- Acertis Pharmaceuticals, Llc
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- November 1, 2022
- Listing Expires
- December 31, 2026
- Application
- NDA018074
Active Ingredients
| Ingredient | Strength |
|---|---|
| Phendimetrazine Tartrate | 105 mg/1 |
Drug Class
Appetite Suppression [PE]Increased Sympathetic Activity [PE]Sympathomimetic Amine Anorectic [EPC]
Selected Package
72989-0409-30Selected30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72989-409-30)